documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

4 rows where docket_id = "FDA-2006-P-0280" and posted_year = 2008 sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: subtype, posted_date (date), comment_start_date (date), last_modified (date)

document_type 2

posted_year 1

  • 2008 · 4 ✖

agency_id 1

id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2006-P-0280-0005 FDA ANDA Suitability for Propoxyphene Napsylate and Acetaminophen-CLOSED FDA-2006-P-0280 Background Materials re: Citizen Petition from Lachman Consultant Services, Inc.- Attachment 1 - Approved Drug Products with Therapeutic Equivalence Evaluations, Electronic Orange Book listing Accessed December 6, 2006 Supporting & Related Material Background Material 2008-11-19T05:00:00Z 2008 11     2024-12-10T18:28:32Z   0 0 09000064804585da
FDA-2006-P-0280-0006 FDA ANDA Suitability for Propoxyphene Napsylate and Acetaminophen-CLOSED FDA-2006-P-0280 Background Materials re: Citizen Petition from Lachman Consultant Services, Inc. - Attachment 4 - List of products approved in Electronic Orange Book with 400 mg dosage strength of Acetaminophen Supporting & Related Material Background Material 2008-11-19T05:00:00Z 2008 11     2024-12-10T18:29:28Z   0 0 09000064804585e0
FDA-2006-P-0280-0003 FDA ANDA Suitability for Propoxyphene Napsylate and Acetaminophen-CLOSED FDA-2006-P-0280 Citizen Petition from Lachman Consultant Services, Inc Other Citizen Petition 2008-11-19T05:00:00Z 2008 11 2008-11-19T05:00:00Z   2024-12-10T18:25:17Z   0 0 09000064804585d8
FDA-2006-P-0280-0004 FDA ANDA Suitability for Propoxyphene Napsylate and Acetaminophen-CLOSED FDA-2006-P-0280 Background Materials re: Citizen Petition from Lachman Consultant Services, Inc. - Attachment 2 - Approved labeling for Reference-Listed Drug Product (RLD), Darvocet-N 1000 Tablets (Xanodyne), Rev. 07-2004 Supporting & Related Material Background Material 2008-11-19T05:00:00Z 2008 11     2024-12-10T18:27:35Z   0 0 09000064804585d0

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options: 

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);